(R)-1-((4-(3-((2-Aminoethyl)disulfanyl)propoxy)-3-methoxyphenethyl)amino)-3-(naphthalen-1-yloxy)propan-2-ol

ID: ALA4463925

PubChem CID: 155529870

Max Phase: Preclinical

Molecular Formula: C27H36N2O4S2

Molecular Weight: 516.73

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(CCNC[C@@H](O)COc2cccc3ccccc23)ccc1OCCCSSCCN

Standard InChI:  InChI=1S/C27H36N2O4S2/c1-31-27-18-21(10-11-26(27)32-15-5-16-34-35-17-13-28)12-14-29-19-23(30)20-33-25-9-4-7-22-6-2-3-8-24(22)25/h2-4,6-11,18,23,29-30H,5,12-17,19-20,28H2,1H3/t23-/m1/s1

Standard InChI Key:  QJSQCJQXYAAGGS-HSZRJFAPSA-N

Molfile:  

 
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
    4.8371  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5489  -16.9299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2567  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9685  -16.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6803  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9685  -16.1086    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3922  -16.9299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1040  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8158  -16.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4139  -18.1571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1307  -18.5696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8392  -18.1552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4144  -17.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1237  -16.9294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1241  -16.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4160  -15.7025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7060  -16.1171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7090  -16.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5277  -17.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5258  -18.1609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2368  -18.5735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9455  -18.1607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9429  -17.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2354  -16.9304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6533  -16.9241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6579  -18.5725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6504  -16.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3692  -18.1589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0815  -18.5706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7928  -18.1570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5052  -18.5688    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.2165  -18.1551    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.9248  -18.5669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6360  -18.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3484  -18.5650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  6
  5  7  1  0
  7  8  1  0
  8  9  1  0
  1 14  2  0
 13 10  2  0
 10 11  1  0
 11 12  2  0
 12  1  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  9 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 23 25  1  0
 22 26  1  0
 25 27  1  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4463925

    ---

Associated Targets(Human)

ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adrb1 Beta-1 adrenergic receptor (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 516.73Molecular Weight (Monoisotopic): 516.2116AlogP: 4.53#Rotatable Bonds: 17
Polar Surface Area: 85.97Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 3.67CX LogD: -0.38
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.18Np Likeness Score: -0.34

References

1. Schwalbe T, Huebner H, Gmeiner P..  (2019)  Development of covalent antagonists for β1- and β2-adrenergic receptors.,  27  (13): [PMID:31151791] [10.1016/j.bmc.2019.05.034]

Source